Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

THERAPY

NSAIDs not linked to worse COVID-19 outcomes

In contrast to anecdotal reports that pre-existing use of NSAIDs is linked to poor outcomes in patients with COVID-19, the findings of a prospective, multicentre cohort study found no increase in mortality or COVID-19 severity among NSAID users. The study included 72,179 patients across 255 health-care facilities in England, 4,211 (5.8%) of whom were taking systemic NSAIDs before they were admitted to hospital.

References

Original article

  1. Drake, T. M. et al. Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study. Lancet https://doi.org/10.1016/S2665-9913(21)00104-1 (2021)

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Sarah Onuora.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Onuora, S. NSAIDs not linked to worse COVID-19 outcomes. Nat Rev Rheumatol 17, 378 (2021). https://doi.org/10.1038/s41584-021-00645-8

Download citation

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing